Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
Launched by BOSTON CHILDREN'S HOSPITAL · Feb 23, 2021
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying genetic factors related to strabismus (when the eyes are not aligned) and nystagmus (involuntary eye movement) to understand how these conditions may run in families. Researchers are looking for families that have multiple members affected by strabismus, as well as individuals with a specific type of strabismus called infantile esotropia or those with infantile nystagmus, along with their parents and siblings. By examining the DNA of these families, the study aims to identify genetic variations that may contribute to these eye conditions.
To participate in this study, you need to be part of a family with at least three relatives who have strabismus, or have a family member with infantile esotropia or infantile nystagmus. Both affected and non-affected family members are welcome to join. Participants can expect to provide DNA samples through blood or saliva, which will help researchers learn more about the genetic causes of these conditions. This research is important as it may lead to better understanding, diagnosis, and treatment options for strabismus and nystagmus in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Member of a family with at least 3 biological relatives with strabismus. (Both affected and non-affected family members will be enrolled).
- • OR
- • - Member of a family with at least 1 individual with infantile esotropia. (Both affected and non-affected family members will be enrolled).
- • OR
- • - Member of a family with at least 1 individual with infantile nystagmus. (Both affected and non-affected family members will be enrolled).
- Exclusion Criteria:
- • paralytic strabismus in affected family members
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Mary Whitman, MD/PhD
Principal Investigator
Assistant Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials